New heart stent study aims to improve artery treatment

NCT ID NCT05981911

First seen Jan 08, 2026

Summary

This study compares a new type of heart stent (XIENCE Skypoint) with other drug-coated stents in 2000 people with coronary artery disease. The goal is to see which stent is more effective and safer in real-world use. Participants will be followed for at least one year to track outcomes like death, heart attack, or the need for another procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asan Medical Hospital

    RECRUITING

    Seoul, South Korea

    Contact Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.